Buchborn T
Laboratory for Neuronal Circuit Dynamics, Imperial College London, London, UK.
ArticlePsilocybin
Psilocybin enhances sociability only in altered behavioural state and does not need an awake experience to be effective.
PreprintIbogaine
Oxa-noribogaine reduces alcohol drinking through aversion learning and by altering glutamatergic activity in the mPFC
ArticlePsilocybin
Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.
ArticlePsilocybin
Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.
PreprintPsilocybin
Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
PreprintPsilocybin
Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
PreprintPsilocybin
Lasting effect of psilocybin on sociability can be blocked by DNA methyltransferase inhibition
PreprintPsilocybin
Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases
ArticlePsychedelics
The ego in psychedelic drug action - ego defenses, ego boundaries, and the therapeutic role of regression.
ArticlePsychedelics
Cortical Correlates of Psychedelic-Induced Shaking Behavior Revealed by Voltage Imaging.
ArticlePsilocybin
Body mass index (BMI) does not predict responses to psilocybin.
ArticlePsychedelics
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.
ArticlePsychedelics